The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Protein concentration is above or equal to 0.05 mg/ml. This protein is best used within three months from the date of receipt.
Concentration information loading...
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.
pH: 8.00 Constituents: 0.79% Tris HCl, 0.3% Glutathione
AT like disease
Ataxia telangiectasia disorder like
DNA recombination and repair protein
Double strand break repair protein MRE11A
Double-strand break repair protein MRE11A
meiotic recombination (S. cerevisiae) 11 homolog A
Meiotic recombination 11 homolog 1
Meiotic recombination 11 homolog A
meiotic recombination 11 homolog A (S. cerevisiae)
MRE11 homolog 1
MRE11 homolog A
MRE11 meiotic recombination 11 homolog A
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
Component of the MRN complex, which plays a central role in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11A. RAD50 may be required to bind DNA ends and hold them in close proximity. This could facilitate searches for short or long regions of sequence homology in the recombining DNA templates, and may also stimulate the activity of DNA ligases and/or restrict the nuclease activity of MRE11A to prevent nucleolytic degradation past a given point. The complex may also be required for DNA damage signaling via activation of the ATM kinase. In telomeres the MRN complex may modulate t-loop formation.
Defects in MRE11A are a cause of ataxia telangiectasia-like disorder (ATLD) [MIM:604391]. ATLD is a disease with the same clinical feature than ataxia-telangiectasia but with a somewhat milder clinical course.
Belongs to the MRE11/RAD32 family.
Phosphorylated upon DNA damage, probably by ATM or ATR.
Nucleus. Localizes to discrete nuclear foci after treatment with genotoxic agents.